GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hindustan Bio Sciences Ltd (BOM:532041) » Definitions » Price-to-Free-Cash-Flow

Hindustan Bio Sciences (BOM:532041) Price-to-Free-Cash-Flow : N/A (As of May. 26, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Hindustan Bio Sciences Price-to-Free-Cash-Flow?

As of today (2024-05-26), Hindustan Bio Sciences's share price is ₹8.55. Hindustan Bio Sciences's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₹0.00. Hence, Hindustan Bio Sciences's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Hindustan Bio Sciences's Price-to-Free-Cash-Flow or its related term are showing as below:

During the past 13 years, Hindustan Bio Sciences's highest Price-to-Free-Cash-Flow Ratio was 4.93. The lowest was 0.00. And the median was 0.00.

BOM:532041's Price-to-Free-Cash-Flow is not ranked *
in the Drug Manufacturers industry.
Industry Median: 23.77
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Hindustan Bio Sciences's Free Cash Flow per Share for the three months ended in Dec. 2023 was ₹0.00. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was ₹0.00.

During the past 13 years, Hindustan Bio Sciences's highest 3-Year average Free Cash Flow per Share Growth Rate was 428.20% per year. The lowest was 6.10% per year. And the median was 29.40% per year.


Hindustan Bio Sciences Price-to-Free-Cash-Flow Historical Data

The historical data trend for Hindustan Bio Sciences's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hindustan Bio Sciences Price-to-Free-Cash-Flow Chart

Hindustan Bio Sciences Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 1.80 4.08 - -

Hindustan Bio Sciences Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Hindustan Bio Sciences's Price-to-Free-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Hindustan Bio Sciences's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hindustan Bio Sciences's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hindustan Bio Sciences's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Hindustan Bio Sciences's Price-to-Free-Cash-Flow falls into.



Hindustan Bio Sciences Price-to-Free-Cash-Flow Calculation

Hindustan Bio Sciences's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=8.55/0
=N/A

Hindustan Bio Sciences's Share Price of today is ₹8.55.
Hindustan Bio Sciences's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Hindustan Bio Sciences  (BOM:532041) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Hindustan Bio Sciences Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Hindustan Bio Sciences's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Hindustan Bio Sciences (BOM:532041) Business Description

Traded in Other Exchanges
N/A
Address
Road No. 2, Banjara Hills, H.No. 8-2-269/S, Plot No. 31, Sagar Co-Operative Housing Society, Hyderabad, TG, IND, 500034
Hindustan Bio Sciences Ltd is an India-based company operating in the pharmaceutical and biotechnology sector. It is engaged in the trading of Drugs and Medicines. The company markets a nephrology product, Recombinant Human Erythropoietin, which is useful for the treatment of anemia associated with chronic renal failure. In addition, the firm also manufactures and markets pharmaceutical products in different forms such as tablets, capsules, drops, externals, and syrups. Its other formulations comprise Pantorest, Maxion, Edinil, Aromycin, Livohin and others. Geographically, the group sells its products within India and also exports it to other countries.

Hindustan Bio Sciences (BOM:532041) Headlines

No Headlines